The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference models
In 2018, China began to gradually promote the pilot policy of centralized band purchasing of medicines. Implementing this policy has resulted in a significant decrease in drug prices. However, there needs to be a clear consensus on the impact and mechanism of action on the innovation of pharmaceutic...
Saved in:
Main Authors: | Xinqing Chen (Author), Shiyi Chen (Author), Zikun Wu (Author), Su Wang (Author), Yuwen Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies
by: Jialin Zhu, et al.
Published: (2023) -
Research on the impact of technology mergers and acquisitions on corporate performance: an empirical analysis based on China's pharmaceutical industry
by: Jialin Yang, et al.
Published: (2024) -
The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies-An Empirical Study Based on the Difference-in-Differences Model
by: Yanyi Wei, et al.
Published: (2022) -
WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM
by: A. I. Borodin
Published: (2015) -
The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance: Moderating roles of scientific collaboration strength and patent stock
by: Xing-Xiu Wang, et al.
Published: (2022)